# Characterization of Apolipoprotein A-I Pathways in Idiopathic Pulmonary Fibrosis

> **NCT02315586** · — · COMPLETED · sponsor: **National Heart, Lung, and Blood Institute (NHLBI)** · enrollment: 63 (actual)

## Conditions studied

- Idiopathic Pulmonary Fibrosis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02315586
- **Lead sponsor:** National Heart, Lung, and Blood Institute (NHLBI)
- **Sponsor class:** NIH
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01-28
- **Primary completion:** 2016-11-02
- **Final completion:** 2022-02-23
- **Target enrollment:** 63 (ACTUAL)
- **Last updated:** 2024-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02315586

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02315586, "Characterization of Apolipoprotein A-I Pathways in Idiopathic Pulmonary Fibrosis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02315586. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*